|
|
|
ORDER: 1-800-526-5224 | SUPPORT: 1-800-447-3846 | ABOUT US | CONTACT US | HOME |
CHROMOGENIC SUBSTRATES UNIVERSITY | METHODS | PROTEOLYTIC
Determination of proteolytic activity in plasma, serum or euglobulin fractions with Chromogenic Substrate S-2288
Measurement Principle
Several proteases with arginine specificity readily split the substrate H-D-Ile-Pro-Arg-pNA
(chromogenic substrate S-2288). The proteolytic activity is thus determined by the rate at which p-nitroaniline
(pNA) is released. The formation of pNA can be followed spectrophotometrically
at 405 nm by using a recorder (initial rate method).
The correlation between the change in absorbance per minute (DA/min) and the
proteolytic activity is usually linear in the 0.05 - 0.5 µkat/l or 3 - 30 U/l
range. If possible the linearity of the assay should be checked for each
individual type of sample. This can be done by serial dilution of the sample. In
several instances the proteolytic activity may originate from a2-macroglobulin
enzyme complexes.
|
HH-D-Ile-Pro-Arg-pNA + H2O |
proteolytic
activity |
H-D-Ile-Pro-Arg-OH + pNA |
Reagents
| Tris | 12.1 g | (100 mmol/l) |
| NaCl | 6.2 g | (106 mmol/l) |
| Distilled water | 800 ml |
Sample
Dilute the plasma, serum or euglobulin fraction with buffer (Reagent 2) to a
proteolytic activity of 0.05 - 0.5 µkat/l or 3 - 30 U/l.
Method
|
Initial rate method |
|
|
Buffer |
200 µl |
|
Incubate at 37°C |
2-4 min |
|
Diluted sample (20-25°C) |
200 µl |
|
Incubate at 37°C |
2-4 min |
|
Substrate (37°C) |
100 µl |
Mix and transfer sample immediately to a 1 cm semi-microcuvette (preheated to 37°C)
for measurement of the absorbance change in a photometer at 405 nm and at 37°C.
Calculate DA/min.
Calculation
The proteolytic activity in the sample is calculated from the following
formulas:
µkat/l = DA/min
x 5.21 x F
U/l = DA/min
x 313 x F
F = dilution factor (e.g. 10 if the sample is diluted 1:10 before initial rate
determination).
Note: For some enzymes with low Km less substrate can be used.
Bibliography
Bratt G et al. Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukemia. Scand J Haematol 34, 332-339 (1985).
Schoenberger OL et al. Proteolytic activity of human tumor cell lines deriving from bronchial squamous cell carcinoma, pulmonary metastasis of rhabdomyosarcoma and pleural metastasis of mesothelioma. Eur J Respir Dis 71, 434-443 (1987).
Burnouf-Radosevich M and Burnouf T. A therapeutic, highly purified factor XI concentrate from human plasma. Transfusion 32, 861-867 (1992).
Koyama S et al. Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke. Exp Lung Res 22, 1-19 (1996).
|
ORDER LINE: 1-800-526-5224 TECH SUPPORT: 1-800-447-3846 |
|
| ORDER | |